Skip to content

Novavax NVAX Europe — Total long-lived assets

Similar metrics at other companies

Haemonetics logo
HAEEurope — Total long-lived assets
$32.08M+60.2%
IAR
IARTEurope — Total long-lived assets
$56.82M+8.5%
AtriCure logo
ATRCEurope — Long-Lived Assets
$6.02M+6.1%
Distribution Solutions Group, Inc. logo
DSGREurope — Long-Lived Assets
$30.81M+0.3%
Sabre logo
SABREurope — Long-Lived Assets
$17M-22.4%
Atkore logo
ATKREurope — Long-Lived Assets
$48.69M-8.7%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's europe — total long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's europe — total long-lived assets?
Novavax (NVAX) reported europe — total long-lived assets of $6.49M in Q1 2026.
How has Novavax's europe — total long-lived assets changed year-over-year?
Novavax's europe — total long-lived assets increased by 63.2% year-over-year, from $3.97M to $6.49M.
What does europe — total long-lived assets mean?
This metric measures the total value of non-current, tangible, and intangible assets held by the company specifically within its European operations. It reflects the scale of the company's physical infrastructure, manufacturing capabilities, and regional investment footprint. Tracking this balance provides insight into the company's capital allocation strategy and the long-term commitment to maintaining operational capacity in the European market.